Rockville, MD - The Food and Drug Administration (FDA) has issued an updated public health notification on the Gambro Prisma Continuous Renal Replacement System, stemming from reports of continued ...
The Continuous Renal Replacement Therapy Market represents a critical segment within the global healthcare industry, specifically designed to provide life-saving treatment for patients experiencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback